Geron
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Geron and other ETFs, options, and stocks.About GERN
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies.
CEOHarout Semerjian
CEOHarout Semerjian
Employees229
Employees229
HeadquartersFoster City, California
HeadquartersFoster City, California
Founded1990
Founded1990
Employees229
Employees229
GERN Key Statistics
Market cap839.44M
Market cap839.44M
Price-Earnings ratio-10.90
Price-Earnings ratio-10.90
Dividend yield—
Dividend yield—
Average volume6.00M
Average volume6.00M
High today$1.32
High today$1.32
Low today$1.25
Low today$1.25
Open price$1.27
Open price$1.27
Volume4.67M
Volume4.67M
52 Week high$4.09
52 Week high$4.09
52 Week low$1.04
52 Week low$1.04
Stock Snapshot
As of today, Geron(GERN) shares are valued at $1.32. The company's market cap stands at 839.44M, with a P/E ratio of -10.90.
As of 2025-12-08, Geron(GERN) stock has fluctuated between $1.25 and $1.32. The current price stands at $1.32, placing the stock +5.6% above today's low and 0.0% off the high.
Geron(GERN) shares are trading with a volume of 4.67M, against a daily average of 6M.
In the last year, Geron(GERN) shares hit a 52-week high of $4.09 and a 52-week low of $1.04.
In the last year, Geron(GERN) shares hit a 52-week high of $4.09 and a 52-week low of $1.04.
Analyst ratings
67%
of 6 ratingsBuy
66.7%
Hold
16.7%
Sell
16.7%
People also own
Based on the portfolios of people who own GERN. This list is generated using Robinhood data, and it’s not a recommendation.